Bill
A 1510
Improves access to lower-cost generic and biosimilar drugs.
2026-2027 Regular Session
Introduced by Roy Freiman and 1 co-sponsor
The bill requires plans to prioritize cheaper generics and biosimilars on formularies, ban barriers to access, and publish transparent, up-to-date formulary information to lower co
Reported out of Assembly Comm. with Amendments, 2nd Reading